EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --
EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --

Devexperts Opens Up DXcharts to Custom JavaScript Indicators

Posted: 5th Mar 2026

Devexperts has updated DXcharts, its financial charting library, to allow broker development teams to build their own technical indicators using JavaScript, a capability the London-based company says lifts the previous cap on the number of studies firms could deploy.

The feature, which Devexperts calls custom studies, lets client teams write indicators with any calculation logic tied to price data. Developers can run multiple output series, choose from several visualization types, and use a set of built-in functions covering standard technical analysis calculations such as moving averages, standard deviation, and true range.

Custom studies connect directly to the chart and refresh in real time as historical data loads, according to the company.

Brokers Had Been Capped at a Fixed Indicator Set

Before the update, brokers licensing DXcharts were limited to the platform's existing library of over 100 pre-built indicators. That constraint matters in a market where most retail CFD brokers run on a small number of shared platforms, where the charting layer is one of the few areas where differentiation is still possible.

Whether custom JavaScript indicators will prove a meaningful edge in practice depends largely on whether broker development teams have the capacity and inclination to build and maintain proprietary studies.

Devexperts has tried this before. In 2021, the company introduced DXscript, a proprietary scripting language aimed at end traders who wanted to write and share their own indicators. The March 2026 update shifts the focus from traders to the development teams at firms licensing the library, exposing the functionality at the API level and adding utility functions for common TA calculations.

TradingView Has Offered Similar Tools for Years

The space Devexperts is moving into is not unoccupied. TradingView's embeddable charting library has long supported custom indicators through its „custom_indicators_getter configuration,” and Pine Script, TradingView's proprietary scripting language - has been the dominant tool for trader-built studies for years.

Denis Krivolapov, Product Manager of DXcharts at Devexperts, said the update would give firms "more autonomy over their product offering, and help them to set themselves apart from competitors, without the need for extensive customization work."

UI Control Added Alongside Indicator Feature

The release also includes a separate change: firms can now hide or show specific menu items and settings in the DXcharts interface. Devexperts says this gives licensees more control over what traders see without requiring deep modifications to the underlying code.

It is the kind of incremental UI control that most established charting vendors already offer, though a broader roundup of broker platforms in 2026 noted that DXcharts is increasingly competing for the same broker clients as MetaTrader 5, cTrader, and Match-Trader.

Devexperts has been active on the product front in recent months. Last week, its DXtrade platform acquired theScreener, a research data provider, in a move aimed at reducing trader drop-off.

In January, DXtrade Mobile added BrokerIQ integration to extend CRM tools to mobile users, and the company linked up with Arizet to offer a fuller infrastructure stack for prop trading firms.

A year ago, DXcharts added the Devexa AI assistant to handle developer queries around customization and integration, a feature positioned as an onboarding tool for new licensees.

Krivolapov said further updates to DXcharts are planned, though he gave no specifics on timing or scope.

This article was written by Damian Chmiel at www.financemagnates.com.

Source: Finance Magnates

Follow us on
Website Managed by BuiltByGo
Disclaimer: The information provided on FX Axe is for educational and informational purposes only and should not be construed as financial advice. Trading Foreign Exchange (FX), Contracts for Difference (CFDs), and other leveraged financial products involves a high level of risk and may not be suitable for all investors. Leverage can work both to your advantage and disadvantage, and as a result, you may lose more than your initial investment. Before deciding to trade FX, CFDs, or any other financial instrument, you should carefully consider your investment objectives, level of experience, and risk tolerance. You should not invest money that you cannot afford to lose. It is strongly advised that you seek independent financial advice if you have any doubts. FX Axe does not provide investment, tax, legal, or financial advice of any kind. We may receive compensation from brokers and partners featured on this website, but such relationships do not influence our reviews or recommendations. All reviews are based on our own opinions and research and should not be interpreted as endorsements or guarantees of any service. Past performance is not indicative of future results. The trading of FX and CFDs carries a significant risk of loss. By using this website, you acknowledge that FX Axe bears no responsibility for any losses you may incur from your trading activities or reliance on information provided here.

Affiliate Disclosure: Some of the links and references on FX Axe may relate to third-party brokers or service providers. In certain cases, we may receive compensation if you choose to engage with these providers through our website. This helps support the ongoing operation of the site and allows us to continue publishing content at no direct cost to our readers. Our content is created with the aim of being informative and useful. While commercial relationships may exist, we strive to ensure that the information presented remains objective and based on our own research and perspective.
cross